passage bio stock forecast

The firm is developing genetic. Find real-time PASG - Passage Bio Inc stock quotes company profile news and forecasts from CNN Business.

Sustainability Free Full Text Stock Market Integration Of Pakistan With Its Trading Partners A Multivariate Dcc Garch Model Approach Html

PASG a clinical-stage genetic medicines.

. Their forecasts range from 600 to 3400. PASG stock analyst estimates including earnings and revenue EPS upgrades and downgrades. PASG stock quote history news and other vital information to help you with your stock trading and investing.

NASDAQPASG Get Rating Wedbush upped their. In total the offering brought in 216 million for the. According to analysts Passage Bios stock has a predicted upside of 29801 based on their 12-month price targets.

Find the latest Passage Bio Inc. Passage Bio intends to raise 125 million in an upcoming IPO. Our Stock Screener Makes it Effortless to Scan for Stocks With Updates in Real-time.

The average price target is 2060 with a high forecast of 3400 and a low forecast. Passage Bio NASDAQPASG Get Rating last posted its quarterly earnings data on. Passage Bio Inc.

Dec 30 2021 403AM EST. Based on 6 Wall Street analysts offering 12 month price targets for Passage Bio in the last 3 months. PHILADELPHIA March 15 2022 GLOBE NEWSWIRE -- Passage Bio Inc.

Ad Dont miss out on opportunities open an account in 10 minutes. If you are looking for stocks with good return Passage Bio Inc. PASGs average true range ATR is 022.

On average they expect Passage Bios. 913a Nikola stock rises after narrower-than-expected loss revenue of. On average Wall Street analysts predict.

PASG - Passage Bio Inc. Please note that any opinions estimates or. Analyst estimates including PASG earnings per share estimates and analyst recommendations.

Read Where Some of Our Portfolio Managers Analysts See Investment Opportunities. 6 equities research analysts have issued 12-month price objectives for Passage Bios stock. Ad Get the Inside Access Traders Are Using to Profit More and Win Bigger.

The companys stock has been forecasted to trade at an average price of 1814 over the course of. Passage Bio has a fifty-two week low of 281 and a fifty-two week high of 2212. Some analysts who are covering this stock.

Ad Dont miss out on opportunities open an account in 10 minutes. Bruce Goldsmith Courtesy Passage Bio Passages stock jumped 20 on Friday its first day trading from 18 to nearly 22. Passage Bio NASDAQ.

Jan 8 2022 857PM EST. Our analyst reveals value stock is set to grow 30 in 2022. See Passage Bio Inc.

What are analysts forecasts for Passage Bio stock. The main clinical program involves PBGM01 which is being used to treat GM1 gangliosidosis and a phase 12. The average PASSAGE BIO stock price prediction forecasts a potential upside of.

Estimated cash runway extended into Q2 2024. Passage Bio Inc PASG shares closed today at 10 above its 52 week low of 630 giving the company a market cap of 346M. Ad Here Are 10 Investment Themes to Consider When Positioning Portfolios for the Year Ahead.

Summary of all time highs changes and price drops for Passage Bio. Is followed by the analysts listed above. Passage Bio undertakes no obligation to publicly update any forward-looking statement whether written or oral that may be made from time to time whether as a result of.

Furthermore Passage Bio Inc. Ad In this free report we detail why this value stock is our experts top pick. NASDAQPASG to Post Q2 2022 Earnings of 075 Per Share Wedbush Forecasts.

PASG has filed to raise 125 million in an IPO of its common stock according to an S-1 registration statement. The current number of active analytics during the last two years is 1. PASG is covered since 2020.

That PASSAGE BIOs share price could reach 1833 by Mar 8 2023. Passage Bio undertakes no obligation to publicly update any forward-looking statement whether written or oral that may be made from time to time whether as a result of. The 13 analysts offering price forecasts for Passage Bio have a median target of 2462 with a high estimate of 4500 and a low estimate.

What analysts cover Passage Bio. Passage Bio Inc PASG shares closed today at 05 above its 52 week low of 559 giving the company a market cap of 304M.

Passage Bio Inc Share Price Usd0 0001